BIOMAT Database Logo BIOMAT Database Logo

HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates. 1993

R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

2',5'-Oligoadenylates (2-5A) and derivatives are noncompetitive inhibitors of primer/HIV-1 reverse transcriptase complex formation. The mechanism and specificity of this inhibitory action of 2-5A and 2-5A derivatives have been evaluated with 2-5A molecules modified in ribosyl moiety, chain length, extent of 5'-phosphorylation, and 2',5'-phosphodiester linkage. UV covalent cross-linking of preformed complexes of p66/p66 homodimer or p66/p51 heterodimer recombinant HIV-1 reverse transcriptase and the primer analog pd(T)16 allowed analysis of the initial step in HIV-1 reverse transcriptase-catalyzed DNA synthesis. Utilizing this primer binding assay, it is demonstrated that 2-5A and 2-5A derivatives inhibit the binding of pd(T)16 to HIV-1 reverse transcriptase. This inhibition is specific for the 2',5'-internucleotide linkage in that the corresponding 3',5'-adenylate derivatives do not exhibit inhibitory activity. Enhanced inhibitory properties were observed following modifications of the 2-5A molecule which result in an increase in hydrophobicity. Replacement of the D-ribosyl moiety of 2-5A with the 3'-deoxyribosyl moiety increased the inhibition of primer/HIV-1 reverse transcriptase complex formation 15-20%. 2',5'-Phosphorothioate substitution yielded the most effective inhibitors, with Ki's of 7-13 microM. In all cases, inhibition of primer/HIV-1 reverse transcriptase complex formation showed a preference for the 5'-triphosphate moiety. Nonphosphorylated derivatives were not inhibitory; 5'-monophosphate derivatives exhibited little or no inhibition. The inhibition of primer binding to HIV-1 reverse transcriptase correlated well with the inhibition of DNA-directed DNA synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D009843 Oligoribonucleotides A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010777 Photochemistry A branch of physical chemistry which studies chemical reactions, isomerization and physical behavior that may occur under the influence of visible and/or ultraviolet light. Photochemistries
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D000227 Adenine Nucleotides Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Inhibition of viral reverse transcriptase by 2',5'-oligoadenylates.
May 1987, Biochemical and biophysical research communications,
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Inhibition of HIV-1 reverse transcriptase by 5'-triphosphates of 5-substituted uridine analogs.
December 1989, Antiviral research,
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.
April 2016, Chembiochem : a European journal of chemical biology,
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Inhibition of HIV reverse transcriptase by 2',3'-dideoxynucleoside triphosphates.
December 1987, Biochemical pharmacology,
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor.
December 2009, The Journal of biological chemistry,
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Theoretical studies of HIV-1 reverse transcriptase inhibition.
September 2012, Physical chemistry chemical physics : PCCP,
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Observations on the inhibition of HIV-1 reverse transcriptase by catechins.
December 1992, The Biochemical journal,
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.
February 1995, Science (New York, N.Y.),
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
December 1990, Science (New York, N.Y.),
R W Sobol, and W L Fisher, and N L Reichenbach, and A Kumar, and W A Beard, and S H Wilson, and R Charubala, and W Pfleiderer, and R J Suhadolnik
Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
January 2002, Planta medica,
Copied contents to your clipboard!